Illumina to showcase the transformational impact of comprehensive genomic profiling in unlocking precision medicine for cancer patients, at ASCO
Go back to Illumina to showcase the transformational impact of comprehensive genomic profiling in unlocking precision medicine for cancer patients, at ASCO| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 191.20 +1.15 (0.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $190.05 | 52 Week High | $196.47 | |||
| Open | $189.17 | 52 Week Low | $127.10 | |||
| Day High | $194.18 | P/E | 212.44 | |||
| Day Low | $187.09 | EPS | $0.90 | |||
| Volume | 1,909,093 | |||||

